Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans

Chest

Volumn 110, Issue 3, 1996, Pages 698-703

  Kiely, David G ^a   Cargill, Robert I ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

angiotensin II blockade; hypoxemia; pulmonary circulation

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; FUROSEMIDE; OXYGEN; PLACEBO; RENIN; SARALASIN;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0030459463     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.3.698     Document Type: Article

References (33)

1. Von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946; 12:301-20
2. Fishman AP. Hypoxia on the pulmonary circulation: how and where it acts. Circ Res 1976; 38:221-31
3. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease: evaluation and management. Chest 1991; 99:715-23
4. Lang CC, Coutie WJ, Struthers AD, et al. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci 1992; 83:529-33
5. Farber MO, Kiblawi SSO, Strawbridge RA, et al. Studies on plasma vasopressin and the renin-angiotensin aldosterone system in chronic obstructive lung disease. J Lab Clin Med 1977; 90: 373-80
6. Farber MO, Roberts LR, Weinberger MH, et al. Abnormalities of sodium and water handling in chronic obstructive lung disease. Intern Med 1982; 142:1326-30
7. Cargill RI, Lipworth BJ. Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed. Pulm Pharmacol 1994; 7:305-10
8. Berkov S. Hypoxic pulmonary vasoconstriction in the rat: the necessary role of angiotensin II. Circ Res 1974; 35:256-61
9. Alexander JM, Nyby MD, Jasberg KA. Effect of angiotensin on hypoxic pulmonary vasoconstriction in isolated dog lung. J Appl Physiol 1976; 41:84-8
10. Zakheim RM, Mattioli L, Molteni A, et al. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest 1975; 33:57-61
11. Cargill RI, Lipworth BJ. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 1996; 109:424-29
12. Kramer HJ, Glanzer K, Meyer-Lehnert H, et al. Kinin- and non-kinin mediated interactions of converting enzyme inhibitors with vasoactive hormones. J Cardiovasc Pharmacol 1990; 15(suppl):S91-98
13. Fagard R, Amery A, Lijnen P. Angiotensin II and not sodium status is the major determinant of the agonist/antagonistic balance of saralasin's actions. Clin Sci 1980; 59:75S-8S
14. Lipworth BJ, Dagg KD. Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow. Br J Clin Pharmacol 1994; 37:273-78
15. Dabestani A, Mahan G, Gardin JM, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987; 59:662-68
16. Brown RA, Beck JS. Comparison of several groups: the analysis of variance. In: Brolin RA. Medical statistics on microcomputers. London: British Medical Journal Publishing, 1990; 34-42
17. Hollenberg NK, William GH, Burger B, et al. Blockade and stimulation of renal, adrenal and vascular angiotensin II receptors with 1-sar-8-ala angiotensin II in normal man. J Clin Invest 1976; 57:39-46
18. Case DB, Wallace JM, Keim HJ, et al. Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin. Am J Med 1976; 60:825-36
19. Streeten DHP, Anderson GH, Dalakos TH. Angiotensin II blockade: its clinical significance. Am J Med 1976; 60:817-24
20. Pettinger WA, Mitchell HC. Clinical pharmacology of angiotensin antagonist. Fed Proc 1976; 35:2521-25
21. Anderson GH, Dalakos TH, Elias A, et al. Diuretic therapy and response of essential hypertension to saralasin. Ann Intern Med 1977; 87:183-87
22. Bonner G, Preis S, Schunk U, et al. Haemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 1990; 15(suppl 6):S46-56
23. McMurtry IF. Angiotensin is not required for hypoxic constriction in salt solution-perfused rat lungs. J Appl Physiol 1984; 56:375-80
24. Lawrence DL, Skatrud JB, Shenker Y. Effect of hypoxia on atrial natriuretic factor and aldosterone regulation in humans. Am J Physiol Endocrinol Metab 1990; 21:E243-48
25. Yuan XJ, Goldman WF, Tod ML, et al. Contrasting effects of hypoxia and potassium currents in cultured pulmonary and mesenteric artery cells. Am J Physiol 1993; 264(pt 1):L116-23
26. Nabika T, Velletri PA, Lovenberg W, et al. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg] vasopressin in vascular smooth muscle cells. J Biol Chem 1985; 260:4661-70
27. + and angiotensin II increase T-type Ca channel current. Proc Natl Acad Sci 1988; 85:2412-16
28. Matsuda M, Sekiguchi T, Sugishita Y, et al. Reliability of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography. Br Heart J 1986; 56:158-64
29. Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation of pulmonary hypertension by a pulsed-Doppler technique. Circulation 1983; 68:302-09
30. Graetringer WF, Greene ER, Voyles WF. Doppler predictions of pulmonary artery pressure, flow, and resistance in adults. Am Heart J 1987; 113:1426-36
31. Beard JT, Newman JH, Loyd JE, et al. Doppler estimation of changes in pulmonary artery pressure during hypoxic breathing. J Am Soc Echocardiogr 1991; 4:121-30
32. Samet P, Bernstein WH. Acute effects of intravenous ethacrynic acid upon cardiovascular haemodynamics. Am J Med Sci 1968; 255:78-83
33. Mookherjee S, Anis O, Warner R, et al. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Am J Cardiol 1978; 42:987-92